NPR

Critics Trying To Stop A Big Study Of Sepsis Say The Research Puts Patients At Risk

The consumer advocacy group Public Citizen also says the multicenter study of life-threatening sepsis will at best produce confusing results. A Harvard doctor and designer of the research disagrees.
Without including a "control group" of sepsis patients who get the usual mix of drugs and fluids, even a big study comparing two other experimental approaches won't deliver helpful answers, critics say.

A consumer advocacy organization is asking federal health officials Tuesday to halt a large medical study being conducted at major universities nationwide.

Public Citizen says that the study, involving treatment for sepsis, puts patients at risk and will at best produce confusing results.

The seeks to answer a key question about sepsis, which is a common and life-threatening response to infection. Sepsis kills more than 250,000 Americans a year, often by triggering the failure of multiple organs. As patients' blood

You’re reading a preview, subscribe to read more.

More from NPR

NPR3 min readAmerican Government
Bid To Oust Speaker Johnson Fails But GOP Turmoil Remains
The House voted overwhelmingly to set aside a motion by Rep. Marjorie Taylor Greene, R-Ga., to remove Johnson as speaker
NPR4 min read
The Dos And Don'ts Of Lending Money
What do you do if a loved one asks to borrow a big sum of money from you? Experts weigh in on when it's OK to fork over the cash — and when you should probably say no.
NPR3 min read
FTX Says It Will Return Money To Most Of Its Customers
FTX says that nearly all of its customers will receive the money back that they are owed, two years after the cryptocurrency exchange imploded, and some will get more than that.

Related Books & Audiobooks